FDA expands children's ibuprofen recall

The FDA issued an expanded recall of infants' oral ibuprofen solution because it may have potentially higher concentrations of ibuprofen than labeled.

Tris Pharma, Inc., initially recalled the drug in December. The FDA said the company's Infants' Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, were sold at Walmart, CVS and Family Dollar.

Adverse effects that could be experienced include nausea, vomiting, epigastric pain, or more rarely diarrhea. Tinnitus, headache and gastrointestinal bleeding are also possible adverse effects. So far, Tris Pharma has not received any reports of adverse effects.

You can find specific details about the recall on the FDA's website.